BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wellner UF, Shen Y, Keck T, Jin W, Xu Z. The survival outcome and prognostic factors for distal cholangiocarcinoma following surgical resection: a meta-analysis for the 5-year survival. Surg Today 2017;47:271-9. [DOI: 10.1007/s00595-016-1362-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Li R, Lu Z, Sun Z, Shi X, Li Z, Shao W, Zheng Y, Song J. A Nomogram Based on the Log Odds of Positive Lymph Nodes Predicts the Prognosis of Patients With Distal Cholangiocarcinoma After Surgery. Front Surg 2021;8:757552. [PMID: 34765638 DOI: 10.3389/fsurg.2021.757552] [Reference Citation Analysis]
2 Umezawa S, Kobayashi S, Otsubo T. Low preoperative psoas muscle mass index is a risk factor for distal cholangiocarcinoma recurrence after pancreatoduodenectomy: a retrospective analysis. World J Surg Oncol 2022;20:176. [PMID: 35655260 DOI: 10.1186/s12957-022-02627-w] [Reference Citation Analysis]
3 Belkouz A, Wilmink JW, Haj Mohammad N, Hagendoorn J, de Vos-Geelen J, Dejong CHC, Homs MYV, Groot Koerkamp B, van Gulik TM, van Oijen MGH, Punt CJA, Klümpen H. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials. Crit Rev Oncol Hematol 2020;151:102975. [PMID: 32464483 DOI: 10.1016/j.critrevonc.2020.102975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Beetz O, Klein M, Schrem H, Gwiasda J, Vondran FWR, Oldhafer F, Cammann S, Klempnauer J, Oldhafer KJ, Kleine M. Relevant prognostic factors influencing outcome of patients after surgical resection of distal cholangiocarcinoma. BMC Surg. 2018;18:56. [PMID: 30103720 DOI: 10.1186/s12893-018-0384-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
5 Strijker M, Belkouz A, van der Geest LG, van Gulik TM, van Hooft JE, de Meijer VE, Haj Mohammad N, de Reuver PR, Verheij J, de Vos-Geelen J, Wilmink JW, Groot Koerkamp B, Klümpen HJ, Besselink MG; Dutch Pancreatic Cancer Group. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study. Acta Oncol 2019;58:1048-55. [PMID: 30907207 DOI: 10.1080/0284186X.2019.1590634] [Cited by in Crossref: 34] [Cited by in F6Publishing: 15] [Article Influence: 11.3] [Reference Citation Analysis]
6 Chansitthichok S, Chamnan P, Sarkhampee P, Lertsawatvicha N, Voravisutthikul P, Wattanarath P. Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study. Asian Pac J Cancer Prev 2020;21:903-9. [PMID: 32334449 DOI: 10.31557/APJCP.2020.21.4.903] [Reference Citation Analysis]
7 Jiang T, Lyu SC, Zhou L, Wang J, Li H, He Q, Lang R. Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma. World J Gastrointest Surg 2021; 13(9): 1025-1038 [PMID: 34621478 DOI: 10.4240/wjgs.v13.i9.1025] [Reference Citation Analysis]
8 Syskova AY, Stilidi IS, Polyakov AN. PROGNOSTIC FACTORS FOR RESECTABLE COMMON BILE DUCT CANCER. Issled prakt med (Print) 2019;6:69-74. [DOI: 10.17709/2409-2231-2019-6-2-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
9 Shinke G, Yamada D, Eguchi H, Iwagami Y, Akita H, Asaoka T, Noda T, Gotoh K, Kobayashi S, Takeda Y, Tanemura M, Doki Y, Mori M. The postoperative peak number of leukocytes after hepatectomy is a significant prognostic factor for cholangiocarcinoma. Mol Clin Oncol 2019;10:531-40. [PMID: 31007913 DOI: 10.3892/mco.2019.1827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Asukai K, Kawamoto K, Eguchi H, Konno M, Asai A, Iwagami Y, Yamada D, Asaoka T, Noda T, Wada H, Gotoh K, Nishida N, Satoh T, Doki Y, Mori M, Ishii H. Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma. Ann Surg Oncol 2017;24:2344-52. [PMID: 28560603 DOI: 10.1245/s10434-017-5871-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
11 Di Martino M, Koh YX, Syn N, Ken Min Chin, Fernando Burdió, Velázquez PS, Manzoni A, Cacciaguerra AB, Prieto M, Lancellotti F, Malleo G, Marchegiani G, Salvia R, Vennarecci G, Hilal MA, Ielpo B. It is the lymph node ratio that determines survival and recurrence patterns in resected distal cholangiocarcinoma. A multicenter international study. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.02.008] [Reference Citation Analysis]
12 Andrianello S, Marchegiani G, Malleo G, Rusev BC, Scarpa A, Bonamini D, Maggino L, Bassi C, Salvia R. Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer. J Gastrointest Surg 2017;21:527-33. [PMID: 27882511 DOI: 10.1007/s11605-016-3328-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Mori S, Aoki T, Park K, Shiraki T, Sakuraoka Y, Iso Y, Kato M, Kubota K. Impact of preoperative percutaneous transhepatic biliary drainage on post‐operative survival in patients with distal cholangiocarcinoma. ANZ Journal of Surgery 2019;89. [DOI: 10.1111/ans.15329] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
14 Manekeller S, Kalff JC. [Treatment approach for gall bladder and extrahepatic bile duct cancer]. Chirurg 2018;89:880-6. [PMID: 30094707 DOI: 10.1007/s00104-018-0704-4] [Reference Citation Analysis]
15 Fukasawa Y, Takano S, Fukasawa M, Maekawa S, Kadokura M, Shindo H, Takahashi E, Hirose S, Kawakami S, Hayakawa H, Yamaguchi T, Nakayama Y, Inoue T, Sato T, Enomoto N. Form-Vessel Classification of Cholangioscopy Findings to Diagnose Biliary Tract Carcinoma's Superficial Spread. Int J Mol Sci. 2020;21. [PMID: 32392821 DOI: 10.3390/ijms21093311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zhou W, Qian L, Rong Y, Zhou Q, Shan J, Li P, Shi L, Liu H, Sun X. Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma. Radiotherapy and Oncology 2020;147:111-7. [DOI: 10.1016/j.radonc.2020.03.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
17 Tamura S, Ashida R, Sugiura T, Okamura Y, Ito T, Yamamoto Y, Ohgi K, Uesaka K. The prognostic impact of skeletal muscle status and bone mineral density for resected distal cholangiocarcinoma. Clin Nutr 2021;40:3552-8. [PMID: 33358552 DOI: 10.1016/j.clnu.2020.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Zhao Y, Nakanishi Y, Ogino M, Oba M, Okamura K, Tsuchikawa T, Nakamura T, Noji T, Asano T, Tanaka K, Hosoi H, Nakayama T, Mitsuhashi T, Dai C, Hirano S. Validation Study of Tumor Invasive Thickness for Postoperative Prognosis in 110 Patients Who Underwent Pancreatoduodenectomy for Distal Cholangiocarcinoma at a Single Institution. American Journal of Surgical Pathology 2019;43:717-23. [DOI: 10.1097/pas.0000000000001244] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Garnier J, Ewald J, Poizat F, Traversari E, Marchese U, Palen A, Delpero JR, Turrini O. Prospective Evaluation of Resection Margins Using Standardized Specimen Protocol Analysis among Patients with Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma. J Clin Med 2021;10:3247. [PMID: 34362031 DOI: 10.3390/jcm10153247] [Reference Citation Analysis]
20 Bolm L, Petrova E, Weitz J, Rückert F, Wittel UA, Makowiec F, Lapshyn H, Bronsert P, Rau BM, Khatkov IE, Bausch D, Keck T, Wellner UF, Distler M. Prognostic relevance of preoperative bilirubin-adjusted serum carbohydrate antigen 19-9 in a multicenter subset analysis of 179 patients with distal cholangiocarcinoma. HPB (Oxford) 2019;21:1513-9. [PMID: 30956162 DOI: 10.1016/j.hpb.2019.03.363] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
21 Yamazaki S, Takayama T, Mitsuka Y, Yoshida N, Higaki T. Criteria for liver resection for metastasis from bile duct cancer. Surg Today 2021;51:727-32. [PMID: 33034741 DOI: 10.1007/s00595-020-02159-4] [Reference Citation Analysis]
22 Skalicky P, Urban O, Ehrmann J, Svebisova H, Klos D, Tesarikova J, Neoral C, Knapkova K, Lovecek M. The short- and long-term outcomes of pancreaticoduodenectomy for distal cholangiocarcinoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2021. [PMID: 34467956 DOI: 10.5507/bp.2021.043] [Reference Citation Analysis]
23 Bergeat D, Turrini O, Courtin-tanguy L, Truant S, Darnis B, Delpero JR, Mabrut J, Regenet N, Sulpice L. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort. Langenbecks Arch Surg 2018;403:701-9. [DOI: 10.1007/s00423-018-1702-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
24 Ghidini M, Tomasello G, Botticelli A, Barni S, Zabbialini G, Seghezzi S, Passalacqua R, Braconi C, Petrelli F. Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis. HPB (Oxford). 2017;19:741-748. [PMID: 28684194 DOI: 10.1016/j.hpb.2017.05.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
25 Okada R, Shimada H, Otsuka Y, Tsuchiya M, Ishii J, Katagiri T, Maeda T, Kubota Y, Nemoto T, Kaneko H. Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma. Surg Today 2017;47:1492-9. [PMID: 28508195 DOI: 10.1007/s00595-017-1540-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Akita M, Ajiki T, Matsumoto T, Shinozaki K, Goto T, Asari S, Toyama H, Kido M, Fukumoto T, Ku Y. Preoperative Cholangitis Affects Survival Outcome in Patients with Extrahepatic Bile Duct Cancer. J Gastrointest Surg 2017;21:983-9. [DOI: 10.1007/s11605-017-3388-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
27 Suzuki S, Shimoda M, Shimazaki J, Maruyama T, Oshiro Y, Nishida K, Kuroda J, Miyoshi K, Koike N, Harada N. Number of positive lymph nodes and lymphatic invasion are significant prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma. Clin Exp Gastroenterol 2019;12:255-62. [PMID: 31239748 DOI: 10.2147/CEG.S207333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Huang X, Shu J, Yan Y, Chen X, Yang C, Zhou T, Li M. Feasibility of magnetic resonance imaging-based radiomics features for preoperative prediction of extrahepatic cholangiocarcinoma stage. Eur J Cancer 2021;155:227-35. [PMID: 34391055 DOI: 10.1016/j.ejca.2021.06.053] [Reference Citation Analysis]
29 Takahashi T, Kawaji H, Murakawa Y, Hayashizaki Y, Murakami T, Yabushita Y, Homma Y, Kumamoto T, Matsuyama R, Endo I. Significance of HMGA2 expression as independent poor prognostic marker in perihilar and distal cholangiocarcinoma resected with curative intent. Eur J Surg Oncol 2021;47:394-400. [PMID: 32878723 DOI: 10.1016/j.ejso.2020.08.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Ji F, Kang Q, Wang L, Liu L, Ke Y, Zhu Y, Zhang N, Xiong S, Li Y, Zou H. Prognostic significance of the neutrophil-to-lymphocyte ratio with distal cholangiocarcinoma patients. Medicine (Baltimore) 2020;99:e22827. [PMID: 33120809 DOI: 10.1097/MD.0000000000022827] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Petrova E, Rückert F, Zach S, Shen Y, Weitz J, Grützmann R, Wittel UA, Makowiec F, Hopt UT, Bronsert P, Kühn F, Rau BM, Izrailov RE, Khatkov IE, Lapshyn H, Bolm L, Bausch D, Keck T, Wellner UF, Seifert G. Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study. Langenbecks Arch Surg 2017;402:831-40. [PMID: 28612115 DOI: 10.1007/s00423-017-1590-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
32 Li J, Chen Q, Jin B, Shi Y, Wu X, Xu H, Zheng Y, Wang Y, Du S, Lu X, Mao Y, Sang X. Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center. Cancer Manag Res 2020;12:411-7. [PMID: 32021453 DOI: 10.2147/CMAR.S229329] [Reference Citation Analysis]
33 Ma WJ, Jin YW, Wu ZR, Yang Q, Wang JK, Liu F, Shi YJ, Li QS, Cheng NS. Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers. HPB (Oxford) 2020;22:939-49. [PMID: 32349925 DOI: 10.1016/j.hpb.2020.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
34 Kingham TP, Aveson VG, Wei AC, Castellanos JA, Allen PJ, Nussbaum DP, Hu Y, D'Angelica MI. Surgical management of biliary malignancy. Curr Probl Surg 2021;58:100854. [PMID: 33531120 DOI: 10.1016/j.cpsurg.2020.100854] [Reference Citation Analysis]
35 Jansen H, Pape UF, Utku N. A review of systemic therapy in biliary tract carcinoma. J Gastrointest Oncol 2020;11:770-89. [PMID: 32953160 DOI: 10.21037/jgo-20-203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Tamura S, Yamamoto Y, Sugiura T, Okamura Y, Ito T, Ashida R, Ohgi K, Sasaki K, Sugino T, Uesaka K. The evaluation of the 8th and 7th edition of the American joint committee on cancer tumor classification for distal cholangiocarcinoma: the proposal of a modified new tumor classification. HPB (Oxford) 2021;23:1209-16. [PMID: 33358564 DOI: 10.1016/j.hpb.2020.12.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Ishihara S, Horiguchi A, Endo I, Wakaki T, Hirano S, Yamaue H, Yamamoto M. Prognostic impact of the number of metastatic lymph nodes in distal bile duct cancer: An analysis of Japanese registration cases by the study group for biliary surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 2020;27:396-401. [PMID: 32128955 DOI: 10.1002/jhbp.730] [Reference Citation Analysis]
38 Nara S, Esaki M, Ban D, Takamoto T, Shimada K, Ioka T, Okusaka T, Ishii H, Furuse J. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials. Jpn J Clin Oncol 2020;50:1353-63. [PMID: 33037430 DOI: 10.1093/jjco/hyaa170] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
39 Gunasekaran G, Bekki Y, Lourdusamy V, Schwartz M. Surgical Treatments of Hepatobiliary Cancers. Hepatology 2021;73 Suppl 1:128-36. [PMID: 32438491 DOI: 10.1002/hep.31325] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 29.0] [Reference Citation Analysis]
40 Lyu S, Li L, Zhao X, Ren Z, Cao D, He Q. Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy. World J Surg Oncol 2020;18:262. [PMID: 33032609 DOI: 10.1186/s12957-020-02040-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
41 Berardi R, Mocchegiani F, Rinaldi S, Fiordoliva I, Rovinelli F, Caramanti M, Federici A, Burattini M, Morgese F, Torniai M, Marcantognini G, Vivarelli M. Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study. Oncol Ther 2020;8:115-24. [PMID: 32700076 DOI: 10.1007/s40487-020-00112-6] [Reference Citation Analysis]
42 Bahra M. [Surgical treatment of distal cholangiocarcinoma]. Chirurg 2021;92:788-95. [PMID: 34232340 DOI: 10.1007/s00104-021-01453-2] [Reference Citation Analysis]
43 Aghili M, Saberi H, Zadeh MM, Jafari F, Mehrabinejad MM, Dashti H, Saberi P, Yazdi NA. Multimodality treatment in unresectable cholangiocarcinoma. J Contemp Brachytherapy 2020;12:131-8. [PMID: 32395137 DOI: 10.5114/jcb.2020.94582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Chin KM, Di Martino M, Syn N, Ielpo B, Hilal MA, Goh BKP, Koh YX, Prieto M. Re-appraising the role of lymph node status in predicting survival in resected distal cholangiocarcinoma - A meta-analysis and systematic review. Eur J Surg Oncol 2021;47:1267-77. [PMID: 33549378 DOI: 10.1016/j.ejso.2021.01.004] [Reference Citation Analysis]
45 Hayashi H, Jang JY, Kim KS, Choi JS, Takahara T, Choi SH, Hirano S, Yu HC, Uemura S, Unno M. Comparison of pancreaticoduodenectomy and bile duct resection for middle bile duct cancer: A multi-center collaborating study of Japan and Korea. J Hepatobiliary Pancreat Sci 2020;27:289-98. [PMID: 32048467 DOI: 10.1002/jhbp.724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Macias RIR, Cardinale V, Kendall TJ, Avila MA, Guido M, Coulouarn C, Braconi C, Frampton AE, Bridgewater J, Overi D, Pereira SP, Rengo M, Kather JN, Lamarca A, Pedica F, Forner A, Valle JW, Gaudio E, Alvaro D, Banales JM, Carpino G. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions. Gut 2022:gutjnl-2022-327099. [PMID: 35580963 DOI: 10.1136/gutjnl-2022-327099] [Reference Citation Analysis]
47 Akita M, Ajiki T, Ueno K, Tsugawa D, Hashimoto Y, Tanaka M, Kido M, Toyama H, Fukumoto T. Predictors of postoperative early recurrence of extrahepatic bile duct cancer. Surg Today 2020;50:344-51. [PMID: 31549244 DOI: 10.1007/s00595-019-01880-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]